Standard BioTools Inc.
USD1.16
+0.01 (+0.87%)
CEO
Michael Egholm
IPO Date
2011-02-10
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$1.15
Prev. Close
$1.15
Day Low
$1.09
Day High
$1.18
52W Low
$0.87
52W High
$1.72
Market Cap
$0.45B
Volume
3.85M
| 25,729 |
| $1.00 |
| 22 May 2026 | Egholm Michael | director, officer: President & CEO | F-InKind | Disposed | 97,626 | $1.00 |
| 8 Apr 2026 | Egholm Michael | director, officer: President & CEO | A-Award | Acquired | 1,042,373 | $0.00 |
| 8 Apr 2026 | Egholm Michael | director, officer: President & CEO | M-Exempt | Acquired | 196,513 | $0.00 |
| 8 Apr 2026 | Egholm Michael | director, officer: President & CEO | F-InKind | Disposed | 95,014 | $0.91 |
| 8 Apr 2026 | Egholm Michael | director, officer: President & CEO | A-Award | Acquired | 2,345,340 | $0.98 |
| 8 Apr 2026 | Egholm Michael | director, officer: President & CEO | M-Exempt | Disposed | 196,513 | $0.00 |
| 8 Apr 2026 | Mackay Sean | SVP & Chief Business Officer | A-Award | Acquired | 272,107 | $0.00 |
| 8 Apr 2026 | Mackay Sean | SVP & Chief Business Officer | A-Award | Acquired | 612,240 | $0.98 |